Quick highlights
- Tumor marker mainly used for monitoring, not screening
- Trend over time is more useful than a single value
- Can be elevated in non-cancer conditions (jaundice, inflammation)
- Interpretation requires imaging and clinical context
- No fasting usually required
- Useful for treatment response monitoring under clinician care
- Biliary obstruction can falsely elevate—clinician correlation essential
- Home blood collection available in many service areas
- Non-alarmist reporting emphasizes limitations
- SEO coverage: CA 19-9 test, CA19-9 tumor marker, pancreatic cancer marker monitoring
What’s included
Preparation
- Book blood draw (home or lab)
- No fasting unless combined tests require fasting
- Inform clinician about jaundice, gallstones, pancreatitis, or liver disease history
- Disclose recent procedures or bile duct interventions
- Collect serum blood sample via trained phlebotomist
- Download report from <a href='/my-account/'>View reports</a>
- Review trends with clinician (do not interpret single value alone)
- Follow clinician plan for imaging and follow-up
FAQs
A tumor marker that can be elevated in some GI/pancreaticobiliary conditions and some non-cancer conditions.
No. It is mainly used for monitoring under clinician care, not for routine screening.
Usually no.
Yes. Bile duct obstruction/jaundice can raise CA 19-9 even without cancer; clinicians interpret carefully.
No. It is not diagnostic and must be interpreted with imaging and clinical evaluation.
To track trends and treatment response; changes over time can be more informative.
Often same day or within 24 hours.
Serum blood sample.
Yes in many serviceable areas.
Yes. Inflammation and benign conditions can elevate it; context matters.
Imaging, liver function tests, and other clinician-directed investigations.
No. Discuss with your clinician; many non-cancer causes exist.
Download from <a href='/my-account/'>View reports</a>.
Seek clinician evaluation; tumor markers are supportive, not definitive.
Notes
Tumor markers support monitoring, not cancer diagnosis alone.
